Comprehensive Assessment of Inactivation Methods for Madariaga Virus.

Eastern Equine Encephalitis Virus Madariaga Select Agent inactivation protocol

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
30 Jan 2024
Historique:
received: 25 10 2023
revised: 22 01 2024
accepted: 25 01 2024
medline: 24 2 2024
pubmed: 24 2 2024
entrez: 24 2 2024
Statut: epublish

Résumé

The Eastern Equine Encephalitis Virus (EEEV) is an emerging public health threat, with the number of reported cases in the US increasing in recent years. EEEV is a BSL3 pathogen, and the North American strain is a US Federal Select Agent (SA). These restrictions make experiments with EEEV difficult to perform, as high-tech equipment is often unavailable in BSL3 spaces and due to concerns about generating aerosols during manipulations. Therefore, a range of inactivation methods suitable for different downstream analysis methods are essential for advancing research on EEEV. We used heat, chemical, and ultraviolet (UV)-based methods for the inactivation of infected cells and supernatants infected with the non-select agent Madariaga virus (MADV). Although the MADV and EEEV strains are genetically distinct, differing by 8-11% at the amino acid level, they are expected to be similarly susceptible to various inactivation methods. We determined the following to be effective methods of inactivation: heat, TRIzol LS, 4% PFA, 10% formalin, and UV radiation for infected supernatants; TRIzol, 2.5% SDS with BME, 0.2% NP40, 4% PFA, and 10% formalin for infected cells. Our results have the potential to expand the types and complexity of experiments and analyses performed by EEEV researchers.

Identifiants

pubmed: 38399982
pii: v16020206
doi: 10.3390/v16020206
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Howard Hughes Medical Institute
ID : Emerging Pathogens Initiative
Pays : United States
Organisme : NIH HHS
ID : T32 AI055403
Pays : United States
Organisme : NCATS NIH HHS
ID : 5TL1TR001864-08
Pays : United States

Auteurs

RuthMabel Boytz (R)

Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06520, USA.

Kadiatou Keita (K)

Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.

Joanna B Pawlak (JB)

Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.

Maudry Laurent-Rolle (M)

Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06520, USA.
Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Center for Infection and Immunity, Yale University School of Medicine, New Haven, CT 06520, USA.

Classifications MeSH